Despite a big increase in “watchful waiting” in the past 15 years, there’s a new study from the U.S. Department of Veterans Affairs health system shows that overtreatment of prostate cancer persists.

Genomic tests are revolutionizing prostate cancer care, enabling precise, personalized treatment tailored to each patient.

High intensity focused ultrasound (HIFU) is a novel prostate cancer treatment that minimizes side effect while destroying ...

"All My Children" star Colin Egglesfield talked about the support he's received after revealing his third cancer diagnosis ...

Actor Colin Egglesfield has been diagnosed with cancer for the third time in his life. The former "All My Children" star ...

In 2024, Feng received the “Mentorship Award” from ASTRO. In December, the American Society for Clinical Oncology (ASCO) ...

A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests — Decipher, Oncotype DX Genomic ...

State Rep. Charlie Meier released a message Monday that wasn’t about politics or state government issues. It was a personal ...

Tissue-based genomic classifier tests, developed to improve prostate cancer risk assessment and treatment recommendations, ...

Incorporating biomarkers into standard practice enhances diagnostic accuracy, supporting confident treatment decisions and optimizing care.

At the New Mexico Cancer Center in Albuquerque, groundbreaking treatments and compassionate care are changing lives for men facing prostate cancer. With a team of dedicated specialists, their ...